Item 15. Exhibits and Financial Statement Schedules.
33K characters. Original on sec.gov ·
Item 15. Exhibits and Financial Statement Schedules.
(a) Index to Consolidated Financial Statements and Schedules
| Page | |||||
| Consolidated Statements of Earnings for the years ended December 31, 2020, 2019 and 2018 | 59 | ||||
| Consolidated Statements of Comprehensive Earnings for the years ended December 31, 2020, 2019 and 2018 | 60 | ||||
| Consolidated Balance Sheets at December 31, 2020 and 2019 | 61 - 62 | ||||
| Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018 | 63 - 64 | ||||
| Consolidated Statements of Stockholders’ (Deficit) Equity for the years ended December 31, 2020, 2019 and 2018 | 65 | ||||
| Notes to Consolidated Financial Statements | 66 - 115 | ||||
| Report of Independent Registered Public Accounting Firm | 116 - 118 | ||||
| Report of Management on Internal Control Over Financial Reporting | 118 |
Schedules have been omitted either because such schedules are not required or are not applicable.
(b) The following exhibits are filed as part of this Report:
| 101.CAL | — | XBRL Taxonomy Extension Calculation Linkbase. | ||||||||||||
| 101.DEF | — | XBRL Taxonomy Extension Definition Linkbase. | ||||||||||||
| 101.LAB | — | XBRL Taxonomy Extension Label Linkbase. | ||||||||||||
| 101.PRE | — | XBRL Taxonomy Extension Presentation Linkbase. | ||||||||||||
| 104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
- Denotes management contract or compensatory plan or arrangement in which directors or executive officers are eligible to participate.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PHILIP MORRIS INTERNATIONAL INC. | |||||
| By: | /s/ ANDRÉ CALANTZOPOULOS | ||||
| (André Calantzopoulos Chief Executive Officer) |
Date: February 9, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated:
| Signature | Title | Date | ||||||
| /s/ ANDRÉ CALANTZOPOULOS | Chief Executive Officer | February 9, 2021 | ||||||
| (André Calantzopoulos) | ||||||||
| /s/ EMMANUEL BABEAU | Chief Financial Officer | February 9, 2021 | ||||||
| (Emmanuel Babeau) | ||||||||
| /s/ ANDREAS KURALI | Vice President and Controller | February 9, 2021 | ||||||
| (Andreas Kurali) | ||||||||
| *MICHEL COMBES, WERNER GEISSLER, LISA A. HOOK, JENNIFER LI, JUN MAKIHARA, KALPANA MORPARIA, LUCIO A. NOTO, FREDERIK PAULSEN, ROBERT B. POLET | Directors |
| *By: | /s/ ANDRÉ CALANTZOPOULOS | February 9, 2021 | |||||||||
| (André Calantzopoulos Attorney-in-fact) |
Previous: Item 14. Principal Accounting Fees and Services.